Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: AJAG who wrote (2360)	4/16/1999 9:16:00 AM
From: Jill	Read Replies (1) \| Respond to of 10280

The other curious thing is that SEPR may be a momentum play, or even a day-trading play, by people who don't know much about the stock. Could explain some of the volatility? Jill

To: AJAG who wrote (2360)	4/20/1999 10:40:00 PM
From: Ed Ajootian	Read Replies (2) \| Respond to of 10280

Ajag, Re: Sturza's fax, you left out several key points he made. He was concerned that, due to not getting as good labeling as hoped, Xopenex would get off to a _much slower start than even the most conservative analysts have predicted. He threw out an estimate for '99 sales of a "whopping" $12 million!! His 12-month target for the stock is $85. He stated that we can expect Phase II norcisapride trials to get going some time in mid-year, and also SGP may file an NDA for Claritin II as early as the end of this year. I have continued to aggressively dump my stock position and am currently down to about 45% of the initial stake. No plans to buy more until after 3rd quarter earnings are announced. My bet is that this stock is dead money until the end of the year, or at best could move up slightly only to get slammed back down on each quarter's release, due to disapointing Xopenex sales results. Of course, the "Tim & Dave" show could always pull another rabbit out of a hat and sign up some new pharma in some blockbuster deal, and you guys will be laughing your asses off at me. That's a risk I'm willing to take at this time. I still have a lot of hopes for this stock long term and thus have no plans to sell any of my Jan. '01 Leaps. BTW, Tim & Dave deserve huge kudos for doing that latest convertible bond issuance at the time that they did. IMO there's no way in hell they could place $300 mm of bonds that are convertible at $125 at this time. Now SEPR can let the David Maris' and Evan Sturza's of the world trash the hell out of the company and SEPR mgt. don't have to give a good god damn what happens to the stock price. They have enough money to see them through to profitability now.